Quality of reporting of randomized controlled trials in polycystic ovary syndrome

Trials

Volumn 10, Issue , 2009, Pages

  Partsinevelou, Anna ^a   Zintzaras, Elias ^a,b  

^a UNIVERSITY OF THESSALY   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL STUDY; CLINICAL TRIAL; CONSOLIDATED STANDARDS OF REPORTING TRIALS; DISEASE ASSOCIATION; FEMALE FERTILITY; FEMALE INFERTILITY; HUMAN; OVARY POLYCYSTIC DISEASE; QUALITY CONTROL; RANDOMIZATION; STANDARDIZATION; FEMALE; RANDOMIZED CONTROLLED TRIAL; STANDARD;

FEMALE; HUMANS; POLYCYSTIC OVARY SYNDROME; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 71949086760     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-10-106     Document Type: Article

References (35)

1. Djulbegovic B, Loughran TP, Hornung CA, Kloecker G, Efthimiadis EN, Hadley TJ, Englert J, Hoskins M, Goldsmith GH. The Quality of Medical Evidence in Hematology-Oncology. Am J Med 1999, 106(2):198-205. 10.1016/S0002-9343(98)00391-X, 10230750.
2. Moher D, Jadad AR, Tugwell P. Assessing the quality of randomized controlled trials. Current issues and future directions. Int J Technol Assess Health Care 1996, 12(2):195-208. 10.1017/S0266462300009570, 8707495.
3. Altman DG. Better reporting of randomised controlled trials: the CONSORT statement. BMJ 1996, 313(7057):570-1. 2352018, 8806240.
4. Ziogas DC, Zintzaras E. Analysis of the quality of reporting of randomized controlled trials in acute and chronic myeloid leukemia, and myelodysplastic syndromes as governed by the CONSORT statement. Ann Epidemiol 2009, 19(7):494-500. 10.1016/j.annepidem.2009.03.018, 19523596.
5. Papathanasiou AA, Zintzaras E. Assessing the Quality of Reporting of Observational Studies in Cancer. Ann Epidemiol 2009,
6. Pfeifer M, Snodgrass GL. The continued use of retracted invalid scientific literature. JAMA 1990, 263(10):1420-1423. 2406475, 10.1001/jama.263.10.1420.
7. Olkin I. Meta-analysis: reconciling the results of independent studies. Stat Med 1995, 14(5-7):457-472. 10.1002/sim.4780140507, 7792440.
8. Juni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001, 323(7303):42-6. 10.1136/bmj.323.7303.42, 1120670, 11440947.
9. Schulz KF, Chalmers I, Grimes DA, Altman DG. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA 1994, 272(2):125-8. 10.1001/jama.272.2.125, 8015122.
10. Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, Gluud C, Martin RM, Wood AJ, Sterne JA. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008, 15;336(7644):601-5.
11. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995, 273(5):408-412. 10.1001/jama.273.5.408, 7823387.
12. Liberati A, Himel HN, Chalmers TC. A quality assessment of randomized control trials of primary treatment of breast cancer. J Clin Oncol 1986, 4(6):942-951.
13. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP. Does quality of reports of randomized trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1999, 352(9128):609-613.
14. Moher D, Jones A, Lepage L. Use of the CONSORT Statement and quality of reports of randomized Trials: a comparative before-and-after evaluation. JAMA 2001, 285(15):1992-5. 10.1001/jama.285.15.1992, 11308436.
15. Junker C, Egger M, Schneider M, Zellweger T, Antes G. The CONSORT statement. JAMA 1996, 276(23):1876-7. 10.1001/jama.276.23.1876, 8968009.
16. Plint A, Moher D, Morrison A, Schulz K, Altman DG, Hill C, Gaboury I. Does the CONSORT checklist improve the quality of reports of randomized controlled trials? A systematic review. MJA 2006, 185(5):263-7.
17. Moher D, Schulz KF, Altman DG, . for the CONSORT Group The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 2001, 134(8):657-662.
18. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gøtzsche PC, Lang T, . CONSORT GROUP (Consolidated Standards of Reporting Trials) The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001, 134(8):663-94.
19. Rennie D. CONSORT revised -- improving the reporting of randomized trials. JAMA 2001, 285(15):2006-7. 10.1001/jama.285.15.2006, 11308440.
20. McNamee D, Horton R. Lies, damn lies, and reports of RCTs. Lancet 1996, 348(9027):562. 10.1016/S0140-6736(05)64795-2, 8774566.
21. Rennie D. How to report randomized controlled trials: the CONSORT statement. JAMA 1996, 276(8):649. 10.1001/jama.276.8.649, 8773640.
22. Diamanti-Kandarakis E, Koulie CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI. A survey of the polycystic ovary syndrome in the Greek Island of Lesbos: a hormonal and metabolic profile. J Clin Endocrinol Metab 1999, 84(11):4006-11. 10.1210/jc.84.11.4006, 10566641.
23. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004, 19(1):41-7. 10.1093/humrep/deh098, 14688154.
24. Colditz G, Miller JN, Mosteller F. How study design affects outcomes in comparisons of therapy. I: Medical Stat Med 1989, 8(4):441-454.
25. Huwiler-Müntener K, Jüni P, Junker C, Egger M. Quality of reporting of randomized trials as a measure of methodologic quality. JAMA 2002, 287(21):2801-4. 10.1001/jama.287.21.2801, 12038917.
26. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977, 33(2):159-74. 10.2307/2529310, 843571.
27. Egger M, Jüni P, Bartlett C, Holenstein F, Sterne J. How important are comprehensive literature searches and the assessment of trail quality in systematic reviews? Empirical study. Health Technol Assess 2003, 7(1):1-76.
28. Egger M, Zellweger-Zähner T, Schneider M, Junker C, Lengeler C, Antes G. Language bias in randomised controlled trials published in English and German. Lancet 1997, 350(9074):326-9. 10.1016/S0140-6736(97)02419-7, 9251637.
29. Devereaux PJ, Choi PT, El-Dika S, Bhandari M, Montori VM, Schünemann HJ, Garg AX, Busse JW, Heels-Ansdell D, Ghali WA, Manns BJ, Guyatt GH. An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods. J Clin Epidemiol 2004, 57(12):1232-6. 10.1016/j.jclinepi.2004.03.017, 15617948.
30. Soares HP, Daniels S, Kumar A, Clarke M, Scott C, Swann S, Djulbegovic B, . Radiation Therapy Oncology Group Bad reporting does not mean bad methods for randomized trials: observational study of randomized controlled trials performed by the Radiation Therapy Oncology Group. BMJ 2004, 328(7430):22-4. 10.1136/bmj.328.7430.22, 313900, 14703540.
31. Olivo SA, Macedo LG, Gadotti IC, Fuentes J, Stanton T, Magee DJ. Scales to Assess the Quality of Randomized Controlled Trials: A Systematic Review. Phys Ther 2008, 88:156-175.
32. Lai R, Chu R, Fraumeni M, Thabane L. Quality of randomized controlled trials reporting in the primary treatment of brain tumors. J Clin Oncol 2006, 24(7):1136-1144. 10.1200/JCO.2005.03.1179, 16505433.
33. Dias S, McNamee R, Vail A. Evidence of improving quality of reporting of randomized controlled trials in subfertility. Hum Reprod 2006, 21(10):2617-27. 10.1093/humrep/del236, 16793995.
34. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996, 276(8):637-9. 10.1001/jama.276.8.637, 8773637.
35. Mills E, Wu P, Gagnier J, Devereaux PJ. The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement. Contemporary Clinical Trials 2005, 26(4):480-7. 10.1016/j.cct.2005.02.008, 16054580.